These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11063507)

  • 41. Antibody response to the rubella virus structural proteins in infants with the congenital rubella syndrome.
    de Mazancourt A; Waxham MN; Nicolas JC; Wolinsky JS
    J Med Virol; 1986 Jun; 19(2):111-22. PubMed ID: 3723114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Problems in determining immune status in borderline specimens in an enzyme immunoassay for rubella immunoglobulin G antibody.
    Steece RS; Talley MS; Skeels MR; Lanier GA
    J Clin Microbiol; 1984 Jun; 19(6):923-5. PubMed ID: 6381532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A sol-particle immunoassay for determination of anti-rubella antibodies; development and clinical validation.
    Wielaard F; Denissen A; van der Veen L; Rutjes I
    J Virol Methods; 1987 Aug; 17(1-2):149-58. PubMed ID: 3667854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of commercial methods of enzyme immunoassay (EIA) for the measurement of rubella-specific IgM.
    Echevarría JM; Sáinz C; De Ory F; Nájera R
    J Virol Methods; 1985 Jul; 11(3):177-87. PubMed ID: 3897258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the immunoenzymatic method for the study of rubella virus antibodies in relation to the traditional hemagglutination-inhibition test].
    Quaglio P; Dattoli A; Aggazzotti G; Mantovani G
    Quad Sclavo Diagn; 1983 Sep; 19(3):399-405. PubMed ID: 6377360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.
    Perrenoud G; Messerli F; Thierry AC; Beltraminelli N; Cousin P; Fasel N; Vallet V; Demotz S; Duchosal MA; Moulon C
    Vaccine; 2004 Dec; 23(4):480-8. PubMed ID: 15530696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells.
    Cordoba P; Grutadauria S; Cuffini C; Zapata M
    Viral Immunol; 2000; 13(1):83-92. PubMed ID: 10733171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of novel synthetic peptide-based DETECT-RUBELLA enzyme immunoassays with Enzygnost and IMx for detection of rubella-specific immunoglobulin G.
    Pedneault L; Zrein M; Robillard L; Landry F; Lacroix M; Joncas J
    J Clin Microbiol; 1994 Apr; 32(4):1085-7. PubMed ID: 8027318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a new enzyme immunoassay based on recombinant Rubella virus-like particles for detection of immunoglobulin M antibodies to Rubella virus.
    Grangeot-Keros L; Enders G
    J Clin Microbiol; 1997 Feb; 35(2):398-401. PubMed ID: 9003604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rubella immunity measured by hemagglutination inhibition and enzyme-linked immunosorbent assay.
    Hornstein L; Swartz TA; Heimann M
    Isr J Med Sci; 1985 Aug; 21(8):666-9. PubMed ID: 4044233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recognition of synthetic peptides with sequences of rubella virus E1 polypeptide by antibodies and T lymphocytes.
    Ilonen J; Seppänen H; Närvänen A; Korkolainen M; Salmi AA
    Viral Immunol; 1992; 5(3):221-8. PubMed ID: 1384533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of enzyme-linked immunosorbent assay, hemagglutination inhibition, and passive latex agglutination for determination of rubella immune status.
    Steece RS; Talley MS; Skeels MR; Lanier GA
    J Clin Microbiol; 1985 Jan; 21(1):140-2. PubMed ID: 3968201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a new latex test and a new enzyme immunoassay for determination of rubella immunity.
    Simor AE; Chua R; Low DE
    J Clin Microbiol; 1988 Aug; 26(8):1582-3. PubMed ID: 3049661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enzyme-linked immunosorbent assay determination of specific rubella antibody levels in micrograms of immunoglobulin G per milliliter of serum in clinical samples.
    Leinikki PO; Shekarchi I; Dorsett P; Sever JL
    J Clin Microbiol; 1978 Oct; 8(4):419-23. PubMed ID: 363739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological characterisation of the rubella E 1 glycoprotein. Brief report.
    Ho-Terry L; Terry GM; Cohen A; Londesborough P
    Arch Virol; 1986; 90(1-2):145-52. PubMed ID: 2425779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serological response to rubella revaccination.
    Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
    JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitive neutralization test for rubella antibody.
    Sato H; Albrecht P; Krugman S; Ennis FA
    J Clin Microbiol; 1979 Feb; 9(2):259-65. PubMed ID: 107192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. R237 and h238 are key amino acids in the rubella virus E1 neutralization epitope.
    Li ZM; Chu FL; Wen HL; Sun ZH; Li GH; Xie WY; Wang ZY
    Viral Immunol; 2014 Nov; 27(9):422-9. PubMed ID: 25226223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
    Qiu Z; Tufaro F; Gillam S
    Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic potential of baculovirus-expressed rubella virus envelope proteins.
    Seppänen H; Huhtala ML; Vaheri A; Summers MD; Oker-Blom C
    J Clin Microbiol; 1991 Sep; 29(9):1877-82. PubMed ID: 1774311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.